Mucosal and systemic HIV-1 Env-specific CD8+ T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector

被引:58
作者
Shata, MT
Reitz, MS
DeVico, AL
Lewis, GK
Hone, DM
机构
[1] Univ Maryland, Inst Biotechnol, Inst Human Virol, Div Vaccine Res, Baltimore, MD 21201 USA
[2] New York Blood Ctr, Lindsley F Kimball Res Inst, Virol Lab, New York, NY 10021 USA
关键词
Salmonella; vaccine; mucosal immunity; human immunodeficiency virus;
D O I
10.1016/S0264-410X(01)00330-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8(+) T-cell responses provide beneficial antiviral immunity against human immunodeficiency virus 1 (HIV-1). In this study, we show that intragastric vaccination with a Salmonella HIV-1 Env DNA vaccine vector generates Env-specific CD8(+) T-cells, both in mucosal and systemic lymphoid tissue. By contrast, intramuscular vaccination with the Env DNA vaccine alone only induced systemic CD8(+) T-cells. To our knowledge, this is the first report showing both mucosal and systemic CD8(+) T-cell responses following vaccination with a Salmonella vaccine vector. These data suggest that this mode of HIV-1 DNA vaccine delivery will be advantageous over parenterally administered HIV-1 DNA vaccines. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:623 / 629
页数:7
相关论文
共 37 条
[1]  
André S, 1998, J VIROL, V72, P1497
[2]   AUTOMATED DNA SEQUENCING - ULTRASENSITIVE DETECTION OF FLUORESCENT BANDS DURING ELECTROPHORESIS [J].
ANSORGE, W ;
SPROAT, B ;
STEGEMANN, J ;
SCHWAGER, C ;
ZENKE, M .
NUCLEIC ACIDS RESEARCH, 1987, 15 (11) :4593-4602
[3]  
AUSUBEL FM, 1990, POLYMERASE CHAIN REA
[4]   Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge [J].
Belyakov, IM ;
Derby, MA ;
Ahlers, JD ;
Kelsall, BL ;
Earl, P ;
Moss, B ;
Strober, W ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1709-1714
[5]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[6]   Oral somatic transgene vaccination using attenuated S-typhimurium [J].
Darji, A ;
Guzman, CA ;
Gerstel, B ;
Wachholz, P ;
Timmis, KN ;
Wehland, J ;
Chakraborty, T ;
Weiss, S .
CELL, 1997, 91 (06) :765-775
[7]  
Fennelly GJ, 1999, J IMMUNOL, V162, P1603
[8]   CONSTRUCTION AND CHARACTERIZATION OF A SALMONELLA TYPHI-BASED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VECTOR VACCINE [J].
FOUTS, TR ;
LEWIS, GK ;
HONE, DM .
VACCINE, 1995, 13 (06) :561-569
[9]   HIGHLY ATTENUATED HIV TYPE-2 RECOMBINANT POXVIRUSES, BUT NOT HIV-2 RECOMBINANT SALMONELLA VACCINES, INDUCE LONG-LASTING PROTECTION IN RHESUS MACAQUES [J].
FRANCHINI, G ;
ROBERTGUROFF, M ;
TARTAGLIA, J ;
AGGARWAL, A ;
ABIMIKU, A ;
BENSON, J ;
MARKHAM, P ;
LIMBACH, K ;
HURTEAU, G ;
FULLEN, J ;
ALDRICH, K ;
MILLER, N ;
SADOFF, J ;
PAOLETTI, E ;
GALLO, RC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (08) :909-920
[10]   Codon usage limitation in the expression of HIV-1 envelope glycoprotein [J].
Haas, J ;
Park, EC ;
Seed, B .
CURRENT BIOLOGY, 1996, 6 (03) :315-324